Order Article Reprints

Olpin SE, Clark S, Dalley J, Andresen BS, Croft J, Scott CA, Khan A, Kirk RJ, Sparkes R, Chard M, et al. Fibroblast Fatty-Acid Oxidation Flux Assays Stratify Risk in Newborns with Presumptive-Positive Results on Screening for Very-Long Chain Acyl-CoA Dehydrogenase Deficiency. International Journal of Neonatal Screening. 2017; 3(1):2. https://doi.org/10.3390/ijns3010002

Olpin, Simon E., Shirley Clark, Jane Dalley, Brage S. Andresen, Joanne Croft, Camilla A. Scott, Aneal Khan, Richard J. Kirk, Rebecca Sparkes, Marisa Chard, and et al. 2017. "Fibroblast Fatty-Acid Oxidation Flux Assays Stratify Risk in Newborns with Presumptive-Positive Results on Screening for Very-Long Chain Acyl-CoA Dehydrogenase Deficiency" International Journal of Neonatal Screening 3, no. 1: 2. https://doi.org/10.3390/ijns3010002

Olpin, S. E., Clark, S., Dalley, J., Andresen, B. S., Croft, J., Scott, C. A., Khan, A., Kirk, R. J., Sparkes, R., Chard, M., Chan, A., Glamuzina, E., Bastin, J., Manning, N. J., & Pollitt, R. J. (2017). Fibroblast Fatty-Acid Oxidation Flux Assays Stratify Risk in Newborns with Presumptive-Positive Results on Screening for Very-Long Chain Acyl-CoA Dehydrogenase Deficiency. International Journal of Neonatal Screening, 3(1), 2. https://doi.org/10.3390/ijns3010002